Hui Cong
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Molecular Biology top 10%
- Circular RNAs in diseases
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- Metabolomics and Mass Spectrometry Studies
Papers in
-
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 15
- Cancer Genomics and Diagnostics 9
- Oncology 20
- Cancer Cells and Metastasis 10
- Co-authors
- Xianjuan Shen (19 shared papers)Shaoqing Ju (18 shared papers)Chunlin Zhuang (6 shared papers)Wannian Zhang (4 shared papers)Zhenyuan Miao (3 shared papers)Shaoqing Ju (7 shared papers)Rongrong Jing (11 shared papers)Xudong Wang (7 shared papers)
- Journals
- Biosensors and Bioelectronics (6 papers)Cancer Biomarkers (3 papers)Oncotarget (3 papers)Journal of Cellular and Molecular Medicine (2 papers)Pathology & Oncology Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hui Cong
89 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 750
- Molecular Biology 1.2k
- Oncology 366
- Biomedical Engineering 353
- Hematology 82
Countries citing papers authored by Hui Cong
This map shows the geographic impact of Hui Cong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Cong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Cong more than expected).
Fields of papers citing papers by Hui Cong
This network shows the impact of papers produced by Hui Cong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Cong. The network helps show where Hui Cong may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Cong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 179 | |
| 2 | 2018 | 157 | |
| 3 | 2016 | 99 | |
| 4 | 2019 | 95 | |
| 5 | 2013 | 90 | |
| 6 | 2019 | 89 | |
| 7 | 2017 | 68 | |
| 8 | 2016 | 63 | |
| 9 | 2015 | 61 | |
| 10 | 2002 | 61 | |
| 11 | 2016 | 51 | |
| 12 | 2018 | 46 | |
| 13 | 2019 | 44 | |
| 14 | 2016 | 44 | |
| 15 | 2012 | 42 | |
| 16 | 2019 | 42 | |
| 17 | 2019 | 38 | |
| 18 | 2020 | 37 | |
| 19 | Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER/NF-κB pathway in non-small-cell lung cancer. | 2019 | 35 |
| 20 | 2018 | 35 |
About Hui Cong
Hui Cong is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Biomedical Engineering, having authored 95 papers that have together received 2.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (14 papers), Cancer Cells and Metastasis (10 papers), Cancer Genomics and Diagnostics (9 papers), Microfluidic and Bio-sensing Technologies (8 papers), Microfluidic and Capillary Electrophoresis Applications (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (750 citations), Molecular Biology (1.2k citations), Oncology (366 citations), Biomedical Engineering (353 citations) and Hematology (82 citations). Hui Cong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xianjuan Shen, Shaoqing Ju, Chunlin Zhuang, Wannian Zhang, Zhenyuan Miao, Shaoqing Ju, Rongrong Jing, Xudong Wang, Hao Ma and Chunping Jia. Their work appears in journals such as Biosensors and Bioelectronics, Cancer Biomarkers, Oncotarget, Journal of Cellular and Molecular Medicine and Pathology & Oncology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.